Technical Specialist

Organization
SpeeDx Ltd
Job Location
The London Bioscience Innovation Centre
2 Royal College Street
London
London
NW1 ONH
United Kingdom
Salary
GBP 47k - 53K
Job Description

The company is now seeking to appoint a Technical Specialist to support the European sales team with its expanding product pipeline comprising infectious disease and anti-microbial resistance. The successful candidate will be based in London and at times be required to travel within the UK and Europe.


Responsibilities

The successful candidate will:

  • Provide technical support for the European sales manager via email, at face-to-face meetings and teleconferences.
  • Present scientific data at conferences and symposiums.
  • Provide hands-on technical support for clinical trials and customers when required and ensure that strict quality standards are maintained.
  • Contribute to technology assessment and market analysis through secondary research and present data internally to the team.
  • Maintain favourable contact with customers (clinicians, key opinion leaders, academics) and other clients.

 

Requirements

You must have the following skills and experience:

  • PhD (Molecular Biology, Biochemistry, Biomedical) with a strong academic record.
  • Demonstrable experience developing key aspects of DNA Analytical / Sequencing or other Molecular Diagnostic technologies.
  • A strong identifiable contribution to optimisation or creation of commercial In Vitro Diagnostic (IVD) products (patents, scientific publications, conference presentations).
  • A high level of proficiency in multiplex PCR and RT-PCR.
  • Extensive knowledge and prior use of fluorescent probes.
  • Experience working with nucleic acid enzymes (DNAzymes, Ribozymes) for diagnostic or therapeutic applications.
  • Strong analytical and problem solving skills.
  • Excellent administrative, organisational, communication and interpersonal skills.
  • Strong secondary research skills, especially scientific literature, patent and internet searches.
  • The ability to work quickly and to deadlines.
  • Excellent interpersonal skills and communication skills.
  • Highly motivated and results driven.

 

  • Experience developing infectious disease diagnostics for use in the clinic.
  • Knowledge of or experience working with SNP discrimination methodologies and/or bacterial/viral assay design.
  • Familiarity with the requirements of obtaining regulatory approval for an IVD product.
  • Experience working within an ISO13485 regulated environment.

We are seeking a candidate with a commercial IVD development background who has a strong work ethic, can demonstrate passion and is driven by success. Working within a highly motivated team in an entrepreneurial business environment, this is an excellent opportunity to join a company at an exciting phase in its development.

 

 

How to Apply

Applications close on the 3rd of February 2017

Email CV with Cover Letter to - [email protected]

 

About Our Organization

SpeeDx is a successful Australian Biotech company which has recently expanded its offices into the UK. Based in Sydney and founded in 2009, SpeeDx is a privately owned company specializing in innovative multiplex real-time polymerase chain reaction (qPCR) solutions for clinical diagnostics. SpeeDx has a portfolio of market-leading detection and priming technologies to enable new healthcare paradigms based on improved delivery and reduced costs. SpeeDx has a proven track record of scientific discovery and strives to provide cutting-edge clinically relevant tools for the clinical diagnostic market. 

New study finds bias against female lecturers among student course evaluations, the Economist reports.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.